NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
The P&L A/C page of Natco Pharma Ltd. presents the key P&L A/c Ratios, its comparison with the sector peers and 5 years of Profit & Loss Account Statement.
The shares have a fixed opening rate and closing rate. The share price for Novelix Pharmaceuticals is ₹24.15 as on Jan 20, 2025. The market cap of Novelix Pharmaceuticals is ₹19.56 Cr as on ...
Reliance share price: After Q3 2025 results, Emkay predicted a ₹1,570 per share target for RIL shares in the long term.(Photo: AFP) According to stock market experts, the Sensex heavyweight ...
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics. By Katie Thomas Maricruz Salgado was bringing her ...
This January, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US, according to data from healthcare research firm 3 Axis Advisors, as reported by ...
Pfizer has reportedly raised the prices of most of its drugs this month, with more than 60 drugs named. Credit: Jonathan Weiss / Shutterstock. This January, pharma companies have announced plans to ...